|
|
Legal status
Patent expired
| (51) | INT.CL.: (2006.01) |
A61P 9/00 A61K 31/135 A61K 31/137 A61P 25/00 |
| (11) | Number of the document | 4455 |
| (13) | Kind of document | B |
| (21) | Application number | 97-200 |
| (22) | Date of filing the application | 1997-12-22 |
| (41) | Date of publication of the application | 1998-09-25 |
| (45) | Date of publication of patent | 1999-01-25 |
| (86) | Number | PCT/US96/07465 |
| Date | 1996-05-22 |
| (87) | Number | WO 96/37199 |
| Date | 1996-11-28 |
| (30) | Number | Date | Country code |
| 446439 | 1995-05-22 | US |
| (71) |
TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD.,
Senate House, Technion City, 32000 Haifa,
IL
TEVA PHARMACEUTICAL INDUSTRIES, LTD., Science Based Industries Campus, Har Hotzvim, P.O. Box 1142, 91010 Jerusalem, IL |
| (72) |
Moussa B. YOUDIM, IL
John P.M. FINBERG, IL Ruth LEVY, IL Jeffrey STERLING, IL David LERNER, IL Haim YELLIN, IL Alex VEINBERG, IL |
| (73) |
TEVA PHARMACEUTICAL INDUSTRIES, LTD.,
Science Based Industries Campus, Har Hotzvim, P. O. Box 1142, 91010 Jerusalem,
IL
TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD., Senate House, Technion City, 32000 Haifa, IL |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | USE OF R-ENANTIOMER OF N-PROPARGYL-1-AMINOINDAN, SALTS, AND COMPOSITIONS THEREOF |
| Payment date | Validity (years) | Amount | |
| 2015-04-22 | 20 | 347.00 EUR |
| Patent expired | ||
| Invalidation date | 2016-05-22 |